Tagatose Market Size, Share, Opportunities, And Trends By Application (Food And Beverages, Pharmaceutical, Others), By Form (Powder, Liquid), By Distribution Channel (Online, Offline), And By Geography - Forecasts From 2023 To 2028

The tagatose market is anticipated to show constant growth during the forecast period.

Tagatose emerges as an appealing ingredient for inclusion in specialized foods for individuals with diabetes due to its unique characteristic of not causing an increase in glucose blood levels upon consumption. It is granted GRAS (Generally Recognized As Safe) status by the U.S. Food and Drug Administration (FDA), and tagatose is officially recognized for use as a sweetener in various food and beverage products.   Beyond its utility as a sweetener, tagatose has been associated with various health benefits, including a reduced risk of tooth decay, improvements in gut health, and a decreased risk of heart disease. The tagatose market is characterized by two primary forms—powder and liquid—offering versatility to manufacturers and caterers to diverse application needs within the food and beverage industry.

Market Drivers

• Rise in the number of diabetic cases.

Preliminary human studies have indicated that Tagatose exhibits a low postprandial blood glucose and insulin response. The prevalence of diabetes is a global health concern, with significant numbers reported in major nations. In 2021, approximately 29.7 million people in the United States, constituting 8.9% of the population, had been diagnosed with diabetes. According to the World Health Organization (WHO), India faces a substantial diabetes burden, with an estimated 77 million individuals above the age of 18 suffering from type 2 diabetes, and nearly 25 million categorized as prediabetics, posing a higher risk of developing diabetes. Given its potential as an alternative to traditional sugar and its demonstrated benefits in glycemic response, tagatose emerges as a noteworthy contender in the market.

• Rising awareness about the health benefits of tagatose.

Consumers are becoming more conscious of the potential advantages of incorporating d-tagatose into their lifestyles, driven by concerns about the potential side effects of modern therapeutic agents. Recognizing its health-promoting properties, the U.S. Food and Drug Administration (FDA) acknowledges d-tagatose as a rare sugar that offers a spectrum of health benefits. These benefits include enhanced glycemic control, reduced risk of cardiovascular disease, lowered susceptibility to tooth decay, and improvements in gut health. Numerous human and animal studies support the safety of d-tagatose consumption, with no adverse effects reported to date. Notably, d-tagatose serves as a general-purpose sweetener in countries such as Korea, Australia, and New Zealand, contributing to its increased awareness and demand.

Market Challenges

• High cost of production.

Despite its promising potential, the tagatose market encounters several challenges stemming from its limited availability and the intricate enzymatic process involved in its production. Currently, tagatose is relatively more expensive compared to other sweeteners due to the complexity of its extraction process. The specialized and multi-step procedures required to extract tagatose from lactose contribute significantly to its production cost. Moreover, the reliance on lactose as the primary raw material for tagatose production introduces vulnerability to fluctuations in dairy markets and potential disruptions in the supply chain. These factors pose a challenge to the consistent availability of tagatose for manufacturers, potentially impacting the feasibility of incorporating tagatose into various products.

The tagatose market by application is segmented into food and beverages, pharmaceuticals, and others.

By application, the Tagatose market is categorized into food and beverages, pharmaceuticals, and other sectors. Within the food and beverage domain, Tagatose has gained popularity as a sought-after alternative to sugar, finding widespread use in a variety of food and beverage products. In the pharmaceutical arena, Tagatose is undergoing exploration as a potential ingredient in diabetic medications and oral care products. This interest is fueled by its distinguished attributes, including a low glycemic index and prebiotic properties. Beyond these primary segments, Tagatose finds utility in "other" categories as well. It may be incorporated into certain cosmetic products where its humectant properties can be beneficial. Additionally, Tagatose's presence in some dietary supplements is notable, particularly in the role of a prebiotic.

North America is anticipated to hold a significant share of the tagatose market.

North America is projected to account for a notable share of the tagatose market, reflecting the region's growing consumer preference for healthy and clean-label products featuring natural ingredients. This shift in consumer behavior aligns seamlessly with the intrinsic appeal of tagatose, known for its low-calorie and low-glycemic properties. Notably, companies like Bonumose, Inc. have achieved significant regulatory and food application milestones in both the United States and Canada. As Bonumose Inc. progresses on schedule for the anticipated opening of its first commercial production facility in Spring 2022, the tagatose market is witnessing increased attention and recognition. The announcement of regulatory achievements underscores the industry's commitment to advancing the use of tagatose, a rare sugar, in various food applications.

Market Developments

• January 2023-  Bonumose Inc. and ASR Group announced that their new Tagtose production facility at Charlottesville, VA started the production of high-quality tagatose intended for a diverse range of food and beverage applications. Utilizing standard equipment alongside a patented enzymatic conversion process.

Company Products

• Spectrum Chemical(L-Tagatose)- Spectrum Chemical, a leading manufacturer and distributor of fine chemicals, ensures the provision of high-quality substances, including L-Tagatose. The company prides itself on delivering products that consistently meet or exceed the grade requirements and specifications for each item in its portfolio. All L-Tagatose products of the company, maintain rigorous standards. The molecular formula for L-Tagatose is C6H12O6, with a molecular weight of 180.16. Spectrum Chemical's dedication to excellence underscores its position as a trusted source of fine chemicals in the industry.
• BLDpharm (D-Tagatose)- Offered by BLDpharm, the product known as D-Tagatose 1-phosphate boasts, a molecular weight of 260.14, and a molecular formula of C6H13O9P. With a remarkable purity level of 97%, this substance adheres to stringent specifications and quality standards. For optimal storage conditions, BLDpharm recommends keeping the product in an inert atmosphere at room temperature. BLDpharm's dedication to providing high-quality chemicals is evident in the meticulous details associated with D-Tagatose 1-phosphate, making it a reliable choice for those seeking precision and reliability in their chemical applications.
• Alfa Chemistry (D-tagatose)-  Provided by Alfa Chemistry, D-tagatose, identified with CAS number 87-81-0, is characterized by its molecular weight of 180.16 and molecular formula C6H12O6. Also known as D-Lyxo-2-hexulose. This white crystalline powder exhibits a boiling point of 232.96 °C, and a flash point of 301.5 °C. With a purity level of 98%, D-tagatose has a density of 1.2805 g/cm³ and a predicted pKa of 11.86±0.20. It is soluble in water and is intended for research use only. Alfa Chemistry provides a comprehensive range of products and services, positioning itself as a trusted source of research materials in the scientific community.

Market Segmentation

• By Application
  • Food And Beverages
  • Pharmaceutical
  • Others
• By Form
  • Powder
  • Liquid
• By Distribution Channel
  • Online
  • Offline
• By Geography
  • North America
    • USA
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Indonesia
    • Thailand
    • Others

1.  INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Research Process

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porter’s Five Force Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. TAGATOSE MARKET BY APPLICATION

5.1. Introduction

5.2. Food and beverages

5.3. Pharmaceutical

5.4. Others

6. TAGATOSE MARKET BY FORM

6.1. Introduction

6.2. Powder

6.3. Liquid

7. TAGATOSE MARKET BY DISTRIBUTION CHANNEL

7.1. Introduction

7.2. Online

7.3. Offline

8. TAGATOSE MARKET BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Spain

8.4.5. Others

8.5. The Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Israel

8.5.4. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia

8.6.6. Thailand

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Market Share Analysis

9.3. Mergers, Acquisitions, Agreements, and Collaborations

10. COMPANY PROFILES

10.1. Rochem International Inc.

10.2. Bonumose, Inc.

10.3. Merck KGaA, Darmstadt,

10.4. DOMINO FOODS, INC.

10.5. GLR Group

10.6. CARL ROTH

10.7. Alfa Chemistry

10.8. LUMITOS AG

10.9. BLDpharm.

10.10. Spectrum Chemical

Rochem International Inc.

Bonumose, Inc.

Merck KGaA, Darmstadt,

DOMINO FOODS, INC.

GLR Group

CARL ROTH

Alfa Chemistry

LUMITOS AG

BLDpharm.

Spectrum Chemical